1-1 of 1
Katharina-Henriette Rasp
Close
Sort by
Journal Articles

FLT3 and KIT Isoforms Activate PI3K/AKT Signaling Which Is Potently Blocked by the Novel Dual PI3K/Mtor Inhibitors NVP-BEZ235 and NVP-BGT226.

Kerstin M Kampa, MD, Sandra Mueller, PhD, Katharina-Henriette Rasp, Lothar Kanz, MD, Michael C Heinrich, MD, Marcus M Schittenhelm, MD
Journal: Blood
Blood (2009) 114 (22): 1740.
https://doi.org/10.1182/blood.V114.22.1740.1740
Published: 2009